Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance
Ovarian Cancer (OVCA) is the most fatal gynecologic cancer and has a 5-year survival rate less than 45%. This is mainly due to late diagnosis and drug resistance. Overexpression of plasma gelsolin (pGSN) is key contributing factor to OVCA chemoresistance and immunosuppression. Gelsolin (GSN) is a mu...
Main Authors: | Toshimichi Onuma, Meshach Asare-Werehene, Yoshio Yoshida, Benjamin K. Tsang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/20/3305 |
Similar Items
-
Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes
by: Meshach Asare-Werehene, et al.
Published: (2022-02-01) -
The regulation of plasma gelsolin by DNA methylation in ovarian cancer chemo-resistance
by: Hafiza Bushra Manzoor, et al.
Published: (2024-01-01) -
The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian Cancer
by: Meshach Asare-Werehene, et al.
Published: (2023-04-01) -
Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumonia
by: Julie V. Catteeuw, et al.
Published: (2021-11-01) -
Plasma gelsolin levels are associated with diabetes, sex, race, and poverty
by: Nicole Noren Hooten, et al.
Published: (2023-03-01)